Friday, 23 May 2014

24, May 2014

Pain and itch blocking antibody discovered

Washington: Scientists have discovered a new antibody that simultaneously blocks the sensations of pain and itching in studies with mice.
According to the researchers of Duke University, the new antibody works by targeting the voltage-sensitive sodium channels in the cell membrane of neurons.
The scientists said that voltage- sensitive sodium channels control the flow of sodium ions through the neuron's membrane and theses channels open and close by responding to the electric current or action potential of the cells, and that one particular type of sodium channel, called the Nav1.7 subtype, is responsible for sensing pain.
The research team first tested the antibody in cultured cells engineered to express the Nav1.7 sodium channel and found that the antibody can bind to the channel and stabilize its closed state.
Seok-Yong Lee, assistant professor of biochemistry in the Duke University Medical School, said that he was originally interested in isolating these sodium channels from cells to study their structure, but they he thought of making an antibody that interferes with the channel function.
The study found that the antibody can also relieve acute and chronic itch in mouse models, making them the first to discover the role of Nav1.7 in transmitting the itch sensation.
Lee added that they now have a compound that can potentially treat both pain and itch at the same time and hope that their discovery will garner interest from pharmaceutical companies that can help us expand our studies into clinical trials.
The study was published online in Cell.
24.05.2014



World's first ever kidney dialysis machine treats multiple organ failure in babies

Washington: Scientists have developed a miniaturised kidney dialysis machine capable of treating the smallest babies that has successfully treated a newborn baby with multiple organ failure for the first time.
According to the researchers, this technology has the potential to revolutionise the treatment of infants with acute kidney injury.
The new continuous renal replacement therapy (CRRT) machine-named CARPEDIEM (Cardio-Renal Pediatric Dialysis Emergency Machine)-was created to overcome the problems of existing dialysis machines that are only designed for adults and have to be adapted for use in newborns and small infants.
Lead author Professor Claudio Ronco from San Bortolo Hospital in Vicenza, Italy, said that such modifications make adult devices inaccurate when used in infants smaller than 15kg and can result in complications with fluid management and treatment delivery.
Ronco added that a major problem is the potential for errors in ultrafiltration volumes, and adult dialysis equipment has a tendency to either withdraw too much fluid from a child, leading to dehydration and loss of blood pressure, or too little fluid, leading to high blood pressure and edema.
The study was published in The Lancet.
24.05.2014







The greater damage for most of us is not that our aim is too high and we miss it, but that it it too low and we reach it
Michelangelo


No comments:

Post a Comment